HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Integra LifeSciences (IART) Investors with Substantial Losses and Persons Who May Assist in Firm’s Investigation into Global Recall and Possible Securities Law Violations to Contact Firm’s Attorneys
July 03, 2023 15:41 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 03, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Integra LifeSciences Holdings Corp. (NASDAQ: IART) investors who suffered substantial losses to submit your losses now. Visit:...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Integra LifeSciences (IART) Investors with Substantial Losses and Persons Who May Assist in Firm’s Investigation into Global Recall and Possible Securities Law Violations to Contact Firm’s Attorneys
June 26, 2023 15:58 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, June 26, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Integra LifeSciences Holdings Corp. (NASDAQ: IART) investors who suffered substantial losses to submit your losses now. Visit:...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Integra LifeSciences (IART) Investors with Substantial Losses and Persons Who May Assist in Firm’s Investigation into Global Recall and Possible Securities Law Violations to Contact Firm’s Attorneys
May 23, 2023 15:17 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 23, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Integra LifeSciences Holdings Corp. (NASDAQ: IART) investors who suffered substantial losses to submit your losses now. ...